BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 24, 2016
View Archived Issues
Allergan completes acquisition of Chase Pharmaceuticals
Read More
Viral Gene announces phase II funding for novel vaccine to prevent colon cancer metastases
Read More
Juno Therapeutics places clinical hold on phase II ROCKET trial of JCAR-015
Read More
Proteros and Merck Sharp & Dohme sign second oncology collaboration on epigenetic target
Read More
SM-04755 demonstrates promise in models of psoriasis, chronic tendinopathy and scleroderma
Read More
LPA receptor 1 as a target for diabetic nephropathy
Read More
Pfizer patents myeloperoxidase irreversible inhibitors
Read More
Genentech and Roche disclose retinoid RORgamma receptor ligands
Read More
Pfizer describes JAK inhibitors
Read More
Rayaldee set for U.S. launch
Read More
Sun Pharma signs definitive agreement to acquire JSC Biosintez
Read More
Sanofi Pasteur MSD vaccines joint venture to end next month
Read More
PRX-OTC from PhaseRx receives FDA orphan drug designation
Read More
European Commission grants conditional marketing authorization for Ninlaro
Read More
Institute of Human Virology announces grants and new international center to tackle HIV/AIDS
Read More
Navidea signs Lymphoseek asset purchase agreement with Cardinal Health
Read More
FDA grants orphan drug designation to ABTL-0812 for the treatment of pancreatic cancer
Read More
NeuroSearch outlines plan for remaining assets after Danish Supreme Court decision
Read More
Filgotinib begins phase III trial in Crohn's disease
Read More
C3c may be useful to monitor psoriatic arthritis
Read More
Arsanis initiates phase II trial of ASN-100 to prevent S. aureus pneumonia
Read More
RGC upregulation may have a pathogenic role in lupus nephritis
Read More
Xencor initiates phase I study of XmAb-13676 for CD20-expressing hematologic malignancies
Read More
